Aurobindo Pharma Ltd
Aurobindo Pharma's Climate Target Data Preview
As of 2024, Aurobindo Pharma has disclosed 1 climate targets aimed at reducing its greenhouse gas (GHG) emissions. These include 1 absolute reduction target, signaling the company’s commitment to managing and lowering its carbon footprint over time. The targets span various emissions scopes and time horizons, offering insight into Aurobindo Pharma ’s climate strategy, ambition level, and alignment with global decarbonization goals.
| Target Type | Scope of Target | Unit | Target | Target Year |
|---|---|---|---|---|
Absolute-based Target | Scope 1 - Total, Scope 2 - Total | Metric Tonnes of CO2 equivalent (mtCO2e) | Copy restricted. Please purchase to unlock this data.  | 2025 |
This table provides a simplified preview of selected climate targets data points. To access the complete dataset with full disclosures, detailed breakdowns, and source traceability, create a free account to view purchase options.
Insights into Aurobindo Pharma's Greenhouse Gas Emissions Pathways
As of 2024, Aurobindo Pharma has set greenhouse gas (GHG) emissions reduction targets that cover its operational emissions (Scope 1 and 2), but not its value chain emissions (Scope 3). This means its reduction efforts currently focus on direct and purchased energy emissions.
Does Aurobindo Pharma have a target to reduce the emissions from its operations?
As of 2024, Aurobindo Pharma has set a target to reduce its operational greenhouse gas (GHG) emissions, specifically those from Scope 1 and Scope 2 sources.
Aurobindo Pharma's most ambitious operational target is to reduce these emissions by 12.5% by 2025, compared to a baseline of 956,095 Metric Tonnes of CO2 equivalent (mtCO2e) in 2020.
Aurobindo Pharma has already surpassed its operational emissions reduction target, with 2024 levels falling below the 2025 value, achieving its climate goal ahead of schedule.